trimethoprim has been researched along with Besnier-Boeck Disease in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaluza, CL | 1 |
| Ewert, EG | 1 |
2 other studies available for trimethoprim and Besnier-Boeck Disease
| Article | Year |
|---|---|
Use of trimethoprim & sulfamethoxazole in the treatment of nasal sarcoidosis.
Topics: Adult; Drug Combinations; Female; Humans; Nose Diseases; Sarcoidosis; Sulfamethoxazole; Trimethoprim | 1991 |
[Treatment of purulent bronchitis during corticosteroid therapy of pulmonary sarcoidosis. Comparative studies on trimethoprim-sulfamethoxazole and tetracycline].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Infective Agents; Bronchitis; Doxycycline; Drug Combina | 1972 |